Clinical Trial Update: Trial of Pazopanib in Patients With Solitary Fibrous Tumor and Extraskeletal Myxoid Chondrosarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of pazopanib in solitary fibrous tumor and extraskeletal myxoid chondrosarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extraskeletal Myxoid Chondrosarcoma
• Solitary Fibrous Tumor

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

Sponsor: Grupo Espanol de Investigacion en Sarcomas | Conditions: Solitary Fibrous Tumor, Extraskeletal Myxoid Chondrosarcoma | Phase 2 | Status: COMPLETED